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Abstract 
The RecQ family of DNA helicases has members 
in all organisms analysed. In humans, defects in 
three family members are associated with disease 
conditions: BLM is defective in Bloom’s syn- 
drome, WRN in Werner’s syndrome and RTS in 
Rothmund-Thomson syndrome. In each case, 
cells from affected individuals show inherent 
genomic instability. The  focus of our work is the 
Bloom’s syndrome gene and its product, BLM. 
Here, we review the latest information concerning 
the roles of BLM in the maintenance of genome 
integrity. 
Background 
The maintenance of chromosome stability is es- 
sential for viability in all organisms. In mammals, 
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a breakdown in genome maintenance is associated 
with both tumorigenesis and cancer progression 
(reviewed in [l]). Cells have, therefore, evolved a 
variety of different mechanisms for ensuring that 
the integrity of the genome is maintained as far as 
is possible, given the many and varied ‘insults’ to 
which the genome is subjected. One group of 
proteins that plays a crucial role in the main- 
tenance of genome stability is the RecQ family, 
named after the Escherichia coli RecQ protein, 
which has multiple members in human cells 
(reviewed in [2]). One of these human RecQ family 
proteins, BLM [3], is defective in the rare disorder 
Bloom’s syndrome (BS), which is associated with 
excessive genomic instability and an enormously 
elevated incidence of cancers (reviewed in [4]). 
The biochemical properties and putative cellular 
roles of BLM will be the subject of this paper. 
BLM and other RecQ family proteins 
The RecQ family is represented in all organisms 
that have been analysed. In the commonly used 
laboratory organisms E .  coli, Saccharomyces cere- 
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Figure I 
Schematic representation of the domain structure of the BLM protein 
The central helicase domain, containing seven conserved motifs, is labelled and shown in grey. 
The N-terminal domain contains two regions with blocks of acidic residues, shown as stippled 
boxes. The C-terminal domain contains a region shown with cross-hatching, adjacent t o  the 
helicase domain, which shows limited identity with a domain in the other RecQ helicases. 
Adjacent to this is the HRDC @elicase and _RNase D C-terminal) domain, shown with light 
stippling, which is a putative nucleic acid binding motif The nuclear localization signal (NLS) 
sequence in the C-terminal domain is shown by a blackvertical bar. The N-terminal43 I amino 
acids have been shown by Beresten et al. [29] t o  oligomerize in vim. This domain is indicated 
by the upper horizontal bar marked ‘oligomerization’. The two regions near the N- and C- 
termini of BLM that medicate interactions with topoisomerase llla are indicated by lower 
horizontal lines. 
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visiae and Schizosaccharomyces pombe, there is a 
single representative: RecQ, Sgslp and Rqhlp 
respectively. In higher eukaryotes there are mul- 
tiple members, with at least five in humans, 
designated BLM, WRN, RECQL, RECQ4 and 
RECQS (reviewed in [2,5,6]). In recent years there 
has been a tremendous upsurge in interest in this 
family following the realization that defects in 
RecQ proteins give rise to at least three clinically 
distinct disorders. As mentioned above, BLM is 
defective in BS, while WRN is defective in 
Werner’s syndrome [7] and RECQ4 is defective 
in Rothmund-Thomson syndrome [8]. The  main 
feature of Werner’s syndrome is the development 
at an abnormally early age of many of the mani- 
festations of the normal aging process, including 
loss and greying of the hair, formation of cataracts, 
loss of subcutaneous fat and osteoporosis (re- 
viewed in [9]). Rothmund-Thomson syndrome is 
associated with skin and skeletal abnormalities, 
but the cellular phenotype has not been charac- 
terized extensively [lo]. All of these disorders are 
associated with a predisposition to cancer, al- 
though this is a particularly striking feature of BS. 
Indeed, BS is unique among cancer predisposition 
syndromes in that individuals with this disorder 
show an increased incidence of all (or nearly all) 
types of cancers, including leukaemias, lym- 
phomas and the common solid epithelial cancers. 
Other features of this disorder include pro- 
portional dwarfism, sunlight sensitivity, immuno- 
deficiency and reduced fertility [4]. 
All RecQ family proteins include a domain of 
approx. 450 amino acids that contains seven highly 
conserved motifs, including a ‘Walker A-box’ 
ATP-binding motif and a DExH box which is a 
characteristic of this family (Figure 1). These 
motifs are found in several DNA and RNA 
helicases. As discussed below, RecQ family 
proteins are 3‘-5‘ DNA helicases. In some cases, 
such as with RecQ and RECQL, the protein 
comprises little more than this ‘ helicase’ domain. 
For other family members, including Sgslp, 
Rqhlp, BLM, WRN and RECQ4, long N- and C- 
terminal domains are also present [2]. The possible 
functional roles of these domains are discussed 
below. 
Phenotype of BS cells 
BS cells show several manifestations of genetic 
instability. The  hallmark feature, which is used in 
the diagnosis of the disorder, is an approx. 10-fold 
elevation in the frequency of sister chromatid 
exchanges [4]. These apparently reciprocal ex- 
changes between sister chromatids have been 
shown to represent homologous recombination 
events [ l l ] .  BS cells also show a mutator pheno- 
type and an increased accumulation of quadri- 
radial chromosomes and other chromosomal 
aberrations, which appear to signify a failure to 
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suppress recombination events occurring between 
homologous chromosomes. BS cells show abnor- 
malities in DNA replication, but these have not 
been characterized in detail. There are reports of 
the accumulation of aberrant replication inter- 
mediates in BS cells, and of a retarded rate of 
replication fork progression [12]. 
Biochemical properties of BLM 
BLM has been purified in recombinant form from 
budding yeast and shown to be a DNA helicase 
that translocates along DNA in the 3’ + 5’ di- 
rection [13]. The active form of BLM is oligo- 
meric, with a molecular mass of approx. 850 kDa. 
Consistent with this, BLM appears to form oligo- 
meric rings, most of which are hexameric [14]. 
The  BLM helicase can unwind a wide variety of 
structurally diverse DNA substrates. However, 
the substrate specificity of BLM is rather atypical 
for a DNA helicase, which may provide clues as to 
the cellular function of the enzyme. BLM does not 
unwind or even bind to blunt-ended, fully duplex 
DNA molecules [15]. It can unwind partial 
duplex molecules if these either contain a single- 
stranded 3’ tail or form a forked structure. Never- 
theless, BLM can unwind certain blunt-ended 
duplexes. In particular, it has been shown that the 
insertion of a 12 bp ‘bubble’ in the centre of an 
otherwise duplex molecule creates a good sub- 
strate for unwinding by BLM (P. Mohaghegh and 
I. D. Hickson, unpublished work). Moreover, 
BLM can unwind a synthetic X-structure, com- 
prising four blunt-ended arms which are a model 
for the Holliday junction recombination inter- 
mediate (see below). Given that these X-structures 
are not thought to contain any single-stranded 
DNA under the conditions used for unwinding (in 
the presence of Mg2+), it may be that BLM effects 
DNA substrate recognition through the recog- 
nition of particular DNA structures and not the 
mere presence of single-stranded DNA. Consist- 
ent with an ability to disrupt X-structures, recent 
data indicate that BLM can promote the ATP- 
dependent branch migration of Holliday junctions 
in vitro [15]. It has been proposed that this activity, 
which is conserved in WRN [16], is involved in 
the suppression of hyper-recombination at sites of 
blocked replication forks. For models of BLM 
function during replication, see [2,6]. 
Another good substrate for BLM, and indeed 
for other RecQ helicases, is G-quadruplex DNA 
[17]. It may be significant that other classes of 
helicase cannot unwind this structure. G-quadru- 
plex DNA is an unusual form of DNA that can 
form (at least in vitro) within G-rich stretches of 
DNA, and comprises a square planer structure 
stabilized by Hoogsteen base pairing. G-DNA is 
significantly more thermostable than a corres- 
ponding B-DNA structure of the same sequence. 
Sequences that can form G-DNA in vitro are 
present in the G-rich strand of human telomeric 
DNA, within ribosomal DNA, and at certain other 
genetic loci (reviewed in [IS]). One potential role 
for BLM and/or other RecQ family helicases is, 
therefore, to disrupt G-DNA structures as and 
when they form in cellular DNA, to permit DNA 
metabolism to occur. For example, during 
DNA replication, G-DNA might form in the 
single-stranded DNA at the fork, and need 
to be disrupted to prevent fork blockade or 
chromosomal breakage/deletion. 
Interactions between BLM and other 
cellular proteins 
BLM has extended N- and C-terminal domains 
that are not obviously conserved in other RecQ 
family helicases [2,3]. It is likely, therefore, that 
these domains impart properties that distinguish 
the functions of BLM from those of other family 
members. One probable role of these extended 
domains is to direct interactions with other nuclear 
proteins. We have studied in detail two protein 
partners for BLM, both of which are likely to be 
relevant to the functions of the enzyme in vivo. 
One partner, replication protein A (RPA), is the 
major binding protein for single-stranded DNA in 
human cells, with roles in DNA replication, repair 
and recombination. The  interaction between 
BLM and RPA is a direct one, as indicated by the 
fact that purified BLM and RPA form a complex 
in vitro [19]. The interaction with BLM is 
mediated by the 70 kDa subunit of the hetero- 
trimeric RPA protein. The interaction has been 
shown to be a functional one, with RPA increasing 
the processivity of the BLM helicase reaction, 
permitting BLM to unwind longer substrates 
(2 259 bp) than it is capable of doing alone. This 
stimulation of BLM helicase activity is not a 
consequence solely of binding of single-stranded 
DNA by RPA, since heterologous single- 
stranded-DNA-binding proteins do not stimulate 
BLM. 
A second binding partner for BLM is topo- 
isomerase IIIa ,  a so-called type IA topoisomerase. 
This interaction is conserved in evolution; for 
example, Sgslp and Top3p form a complex in 
budding yeast [20]. Moreover, the genes encoding 
Sgslp and Top3p in budding yeast, and Rqhlp 
203 0 2001 Biochemical Society 
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and Top3p in fission yeast, show a similar genetic 
interaction, in that the defects seen in top3A 
mutants are in each case suppressed by mutation 
of the corresponding RecQ helicase gene [20-221. 
Yet another connection between RecQ helicases 
and topoisomerase I11 comes from the finding that 
RECQS interacts with both topoisomerase I I Ia  
and IIIP, the two known isoforms of topoiso- 
merase 111 in human cells [23]. The  interaction 
between BLM and topoisomerase I I Ia  is direct 
and is mediated by residues present in both the 
N- and C-terminal domains of BLM [24]. In the 
absence of BLM, in BS cells, topoisomerase I I Ia  
is mis-localized in the nucleus, opening up the 
possibility that defects in topoisomerase I I Ia  
function might underlie at least some of the pheno- 
types of BS cells [24]. The  precise role of the 
BLM-topoisomerase I I Ia  complex is not clear at 
this stage, but Harmon et al. [25] have shown that, 
together, E. coli RecQ and topoisomerase I I Ia  can 
catalyse the catenation of plasmid DNA. It has 
been suggested that such an activity may be 
involved in resolving aberrant recombination in- 
termediates. For a more detailed discussion of this 
and other roles of this helicase-topoisomerase 
complex, see Wu et al. [26]. 
Subcellular localization of BLM 
Using antibodies that are specific for BLM, several 
groups have analysed the subcellular distribution 
of BLM in human cells. There is general agree- 
ment that the bulk of BLM protein is found in 
specific nucleoplasmic foci, where it co-localizes 
with topoisomerase I I Ia  [24]. These foci cor- 
respond to one class of previously characterized 
nuclear structure, termed PML nuclear bodies, 
the functional role of which is currently un- 
certain [27]. BLM is also found at sites of ongoing 
DNA replication, at least under certain circum- 
stances, and in nucleoli [6,28]. Whether BLM 
translocates from site to site to effect its functions 
is not yet clear. 
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